Labcorp acquires MLM Medical Labs, expanding its laboratory network to four continents and strengthening biomarker testing ...

Watchmaker Genomics signed a lease at Flatiron Park in Boulder, Colorado, to more than double its manufacturing capacity.

Thermo Fisher introduces the Multiskan Ease Absorbance Microplate Reader for routine biological assays and streamlined lab ...

The study describes Capture-Seq, a method that isolates more than 99% pure circulating tumor-derived DNA from plasma by targeting transcription factor-protected DNA fragments. VolitionRx Limited ...

The new research assays provide flexible options for detecting the Cyclospora cayetanensis parasite and other gastrointestinal pathogens. Roche, in collaboration with its subsidiary TIB MOLBIOL, has ...

The company says its US business combines automated kit manufacturing, fulfillment, sample logistics, and digital workflow technology into a single diagnostic testing platform. RDi USA Inc announced ...

The autonomous assistant is designed to operate existing laboratory instruments using a facility’s validated procedures. Tactus AI introduced Elsie, an autonomous humanoid laboratory assistant, at the ...

The assay measures lipoprotein(a) levels in molar units to improve cardiovascular risk assessment and standardization across laboratories. The Food and Drug Administration (FDA) has granted 510(k) ...

The test showed 94.4% accuracy and detected cases missed by imaging. HerAnova Lifesciences presented clinical validation data for HerResolve, a blood-based test designed to aid in the diagnosis of ...

The automated PCR test provides results in 20 minutes to help clinicians diagnose common causes of vaginitis during a patient visit. bioMérieux submitted a Dual 510(k)/Clinical Laboratory Improvement ...

The new technologies address library normalization and amplification accuracy for high-throughput and oncology sequencing. Watchmaker Genomics announced the launch of two new technologies designed to ...

The updated treatment algorithm for certain bladder cancers now includes the use of blood-based DNA testing to help guide post-surgical treatment decisions. The National Comprehensive Cancer Network ...